Competing time-to-event endpoints in cardiology trials: A simulation study to illustrate the importance of an adequate statistical analysis

Abstract

Ignoring or not fully accounting for competing risks may yield misleading or even erroneous results, which could hinder understanding of survival trends; therefore, it is important that competing risks methodology be routinely incorporated into clinical trial standards.